Should you be screened for type 2 diabetes? Type 2 diabetes is a disease in which your body cannot produce enough insulin or properly use the insulin it makes.
A Type 2 Diabetes Risk Calculator for Clinicians is available if you require help from your healthcare provider answering some of the questions.
Please note: These recommendations are for screening adults without symptoms of diabetes. They do not apply to those already diagnosed with type 2 diabetes, those at risk for type 1 diabetes, or those with symptoms of diabetes.
Symptoms of diabetes include:
It is important to recognize, however, that many people who have type 2 diabetes may display no symptoms.i
Please speak to your family physician or primary health care provider if you are experiencing one or more of these symptoms.
Determine your risk level by using our Risk Calculator. Add up your points based on your answer to each question to determine your total risk score. Use your score with the results table to determine your risk.
Score | Risk | Recommendation |
---|---|---|
0–14 points | Low to Moderate Risk 1–17% chance of developing diabetes within 10 years. | We recommend not routinely screening for type 2 diabetes. |
15–20 points | High Risk 33% chance of developing diabetes within 10 years. | We recommend screening every 3–5 yearswith A1c. |
21–30 points | Very High Risk 50% chance of developing diabetes within 10 years. | We recommend annual screening with A1c. |
The A1c test is a simple lab test that reflects your average blood glucose level over the last 3 months. A small blood sample to check your A1c can be taken at any time of the day. For more information, please see our Frequently Asked Questions for Patients.
Consult our Frequently Asked Questions for Patients or email us at info@canadiantaskforce.ca.
Finnish Diabetes Risk Score (FINDRISC) questionnaire by Adjunct Professor Jaana Lindström, Diabetes Prevention Unit, Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland and Professor Jaakko Tuomilehto, Center for Vascular Prevention, Danube-University Krems, Krems, Austria